Advances of HER2 testing for women with breast cancer

被引：0

作者：

Chivukula, Mamatha ^{[1
]}

机构：

[1] Mills Peninsula Hosp, Dept Pathol & Lab Med, Burlingame, CA 94010 USA

来源：

TRANSLATIONAL BREAST CANCER RESEARCH | 2023年 / 4卷

关键词：

Human epidermal growth factor receptor 2 (HER2); breast cancer; trastuzumab; in-situ hybridization (ISH); immunohistochemistry (IHC); CONCORDANCE;

D O I：

10.21037/tbcr-23-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 13 条

[1]

[Anonymous], Pandemic Planning Clinical Guideline for Patients with Cancer

[2] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer [J].

Bahreini, Fatemeh ;

Soltanian, Ali Reza ;

Mehdipour, Parvin .

BREAST CANCER, 2015, 22 (06) :615-625

[3] Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium [J].

Dietz, Jill R. ;

Moran, Meena S. ;

Isakoff, Steven J. ;

Kurtzman, Scott H. ;

Willey, Shawna C. ;

Burstein, Harold J. ;

Bleicher, Richard J. ;

Lyons, Janice A. ;

Sarantou, Terry ;

Baron, Paul L. ;

Stevens, Randy E. ;

Boolbol, Susan K. ;

Anderson, Benjamin O. ;

Shulman, Lawrence N. ;

Gradishar, William J. ;

Monticciolo, Debra L. ;

Plecha, Donna M. ;

Nelson, Heidi ;

Yao, Katharine A. .

BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) :487-497

[4] Impact of the 2018 ASCO/CAP HER2 Guideline Focused Update [J].

Gordian-Arroyo, Adlin M. ;

Zynger, Debra L. ;

Tozbikian, Gary H. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (01) :17-26

[5] HER2 in Breast Cancer: A Review and Update [J].

Krishnamurti, Uma ;

Silverman, Jan F. .

ADVANCES IN ANATOMIC PATHOLOGY, 2014, 21 (02) :100-107

[6] Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition) [J].

Li, Jianbin ;

Wang, Xiaojia ;

Wang, Shusen ;

Wang, Shu ;

Wang, Tao ;

Liu, Yueping ;

Geng, Cuizhi ;

Jin, Feng ;

Yin, Yongmei ;

Zhang, Qingyuan ;

Song, Erwei ;

Wu, Jiong ;

Jiang, Zefei .

TRANSLATIONAL BREAST CANCER RESEARCH, 2022, 3

[7] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer [J].

Modi, Shanu ;

Jacot, William ;

Yamashita, Toshinari ;

Sohn, Joohyuk ;

Vidal, Maria ;

Tokunaga, Eriko ;

Tsurutani, Junji ;

Ueno, Naoto T. ;

Prat, Aleix ;

Chae, Yee Soo ;

Lee, Keun Seok ;

Niikura, Naoki ;

Park, Yeon Hee ;

Xu, Binghe ;

Wang, Xiaojia ;

Gil-Gil, Miguel ;

Li, Wei ;

Pierga, Jean-Yves ;

Im, Seock-Ah ;

Moore, Halle C. F. ;

Rugo, Hope S. ;

Yerushalmi, Rinat ;

Zagouri, Flora ;

Gombos, Andrea ;

Kim, Sung-Bae ;

Liu, Qiang ;

Luo, Ting ;

Saura, Cristina ;

Schmid, Peter ;

Sun, Tao ;

Gambhire, Dhiraj ;

Yung, Lotus ;

Wang, Yibin ;

Singh, Jasmeet ;

Vitazka, Patrik ;

Meinhardt, Gerold ;

Harbeck, Nadia ;

Cameron, David A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01) :9-20

[8] HER2 testing across practices-Have we come to a consensus on the ideal method of testing? A systematic literature review [J].

Nassar, Aziza ;

Pooja, Advani ;

Chivukula, Mamatha .

BREAST JOURNAL, 2020, 26 (06) :1185-1188

[9] Concordance between central and local laboratory HER2 testing from a community-based clinical study [J].

Reddy, Josina C. ;

Reimann, James D. ;

Anderson, Steven M. ;

Klein, Pamela M. .

CLINICAL BREAST CANCER, 2006, 7 (02) :153-157

[10] Improving HER2 testing reproducibility in HER2-low breast cancer [J].

Sajjadi, Elham ;

Venetis, Konstantinos ;

Ivanova, Mariia ;

Fusco, Nicola .

CANCER DRUG RESISTANCE, 2022, 5 (04) :882-888

← 1 2 →